These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7762389)

  • 21. [Tolerance and effectiveness of oxymetazoline and xylometazoline in treatment of acute rhinitis].
    Dorn M; Hofmann W; Knick E
    HNO; 2003 Oct; 51(10):794-9. PubMed ID: 14523532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluticasone reverses oxymetazoline-induced tachyphylaxis of response and rebound congestion.
    Vaidyanathan S; Williamson P; Clearie K; Khan F; Lipworth B
    Am J Respir Crit Care Med; 2010 Jul; 182(1):19-24. PubMed ID: 20203244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intranasal corticosteroid and oxymetazoline for chronic rhinitis: a systematic review.
    Neighbors CL; Salvador CF; Zhu B; Camacho M; Tsai P
    J Laryngol Otol; 2022 Jan; 136(1):8-16. PubMed ID: 34702392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of oxymetazoline on lysozyme secretion from the human nasal mucosa.
    Browning S; Housley D; Richards R; Eccles R
    Acta Otolaryngol; 1997 Nov; 117(6):851-5. PubMed ID: 9442826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and Safety of Fluticasone Furoate and Oxymetazoline Nasal Spray: A Novel First Fixed Dose Combination for the Management of Allergic Rhinitis with Nasal Congestion.
    Kumar RS; Jain MK; Kushwaha JS; Patil S; Patil V; Ghatak S; Sanmukhani J; Mittal R
    J Asthma Allergy; 2022; 15():783-792. PubMed ID: 35712651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The nasal airways response in normal subjects to oxymetazoline spray: randomized double-blind placebo-controlled trial.
    Bickford L; Shakib S; Taverner D
    Br J Clin Pharmacol; 1999 Jul; 48(1):53-6. PubMed ID: 10383560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and rhinostereometric assessment of nasal mucosal swelling during histamine challenge.
    Graf P; Hallén H
    Clin Otolaryngol Allied Sci; 1996 Feb; 21(1):72-5. PubMed ID: 8674227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rhinitis medicamentosa: aspects of pathophysiology and treatment.
    Graf P
    Allergy; 1997; 52(40 Suppl):28-34. PubMed ID: 9353558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical vasoconstrictor (oxymetazoline) does not affect histamine-induced mucosal exudation of plasma in human nasal airways.
    Svensson C; Pipkorn U; Alkner U; Baumgarten CR; Persson CG
    Clin Exp Allergy; 1992 Mar; 22(3):411-6. PubMed ID: 1586878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extended use of topical nasal decongestants.
    Yoo JK; Seikaly H; Calhoun KH
    Laryngoscope; 1997 Jan; 107(1):40-3. PubMed ID: 9001263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined intranasal ipratropium bromide and oxymetazoline in experimental rhinovirus infection.
    Pitkäranta A; Wecker MT; Korts DC; Hayden FG
    Am J Rhinol; 1998; 12(2):125-9. PubMed ID: 9578931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxymetazoline Applied Topically to the Nasal Mucosa Decreases Trans-Mucosal Nitrous Oxide Exchange for the Middle Ear.
    Teixeira MS; Alper CM; Martin BS; Helal N; Doyle BM; Doyle WJ
    Ann Otol Rhinol Laryngol; 2016 May; 125(5):400-7. PubMed ID: 26611245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of a new administration form of oxymetazoline on maxillary ostial patency in healthy individuals and patients with acute rhinitis.
    Ackerhans M; Jannert M; Tönnesson M
    Acta Otolaryngol Suppl; 1994; 515():49-52. PubMed ID: 8067244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in nasal reactivity in patients with rhinitis medicamentosa after treatment with fluticasone propionate and placebo nasal spray.
    Graf PM; Hallén H
    ORL J Otorhinolaryngol Relat Spec; 1998; 60(6):334-8. PubMed ID: 9742282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse effects of benzalkonium chloride on the nasal mucosa: allergic rhinitis and rhinitis medicamentosa.
    Graf P
    Clin Ther; 1999 Oct; 21(10):1749-55. PubMed ID: 10566570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of micronized cellulose powder on the efficacy of topical oxymetazoline in allergic rhinitis.
    Valerieva A; Popov TA; Staevska M; Kralimarkova T; Petkova E; Valerieva E; Mustakov T; Lazarova T; Dimitrov V; Church MK
    Allergy Asthma Proc; 2015; 36(6):e134-9. PubMed ID: 26133030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pathophysiology and treatment of rhinitis medicamentosa.
    Graf P; Hallén H; Juto JE
    Clin Otolaryngol Allied Sci; 1995 Jun; 20(3):224-9. PubMed ID: 7554332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis.
    Banov CH; Lieberman P;
    Ann Allergy Asthma Immunol; 2001 Jan; 86(1):28-35. PubMed ID: 11206234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ultrastructural changes in human nasal mucosa in rhinitis medicamentosa].
    Knipping S; Holzhausen HJ; Riederer A; Bloching M
    HNO; 2006 Oct; 54(10):742-8. PubMed ID: 16477462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis.
    Corren J; Storms W; Bernstein J; Berger W; Nayak A; Sacks H;
    Clin Ther; 2005 May; 27(5):543-53. PubMed ID: 15978303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.